We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Adeptus Health (ADPT) Q2 Earnings: Will it Beat Estimates?
Read MoreHide Full Article
Adeptus Health, Inc. (ADPT - Free Report) is set to report second-quarter 2016 results on Jul 21. Last quarter, the company reported earnings of 41 cents per share, which exceeded the Zacks Consensus Estimate by 4 cents.
We note that, on an average, Adeptus Health posted a positive earnings surprise of 65.83% over the last four quarters.
Let’s see how things are shaping up prior to this announcement.
Factors at Play
Adeptus Health continues to introduce and enhance its facilities on a steady clip by establishing partnerships with the leading health care systems of the market. We believe significant growth in same-store revenues, accompanied by increasing patient volumes, is likely to be the key catalyst for the company’s growth.
Adeptus Health continues to expand its network of hospitals around the U.S. In addition to the existing hospitals in Phoenix and Dallas, it has two more hospitals under construction in Colorado and one in Houston. The hospital in Louisiana is slated to begin its operations by the end of the year.
However, second-quarter results are expected to be hurt by operating losses from the First Texas Hospital, along with incremental operating costs related to the launch of new hospitals.
Earnings Whispers
Our proven model does not conclusively show that Adeptus Health is likely to beat earnings this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. This is not the case here as you will see below.
Zacks ESP: Adeptus Health currently has an Earnings ESP of 0.00%. This is because the Most Accurate estimate and the Zacks Consensus Estimate for the stock stand at 48 cents.
Zacks Rank: Adeptus Health carries a Zacks Rank #5 (Strong Sell). Please note that we caution against stocks with a Zacks Rank #4 or 5 (Sell-rated) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks to Consider
Here are some companies you may want to consider as our model shows they have the right combination of elements to post an earnings beat this quarter:
CytRx Corporation with an Earnings ESP of +15.00% and a Zacks Rank #1.
Innoviva Inc. (INVA - Free Report) with an Earnings ESP of +25.00% and a Zacks Rank #1.
WellCare Health Plans Inc. with an Earnings ESP of +1.45% and a Zacks Rank #1.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Adeptus Health (ADPT) Q2 Earnings: Will it Beat Estimates?
Adeptus Health, Inc. (ADPT - Free Report) is set to report second-quarter 2016 results on Jul 21. Last quarter, the company reported earnings of 41 cents per share, which exceeded the Zacks Consensus Estimate by 4 cents.
We note that, on an average, Adeptus Health posted a positive earnings surprise of 65.83% over the last four quarters.
Let’s see how things are shaping up prior to this announcement.
Factors at Play
Adeptus Health continues to introduce and enhance its facilities on a steady clip by establishing partnerships with the leading health care systems of the market. We believe significant growth in same-store revenues, accompanied by increasing patient volumes, is likely to be the key catalyst for the company’s growth.
Adeptus Health continues to expand its network of hospitals around the U.S. In addition to the existing hospitals in Phoenix and Dallas, it has two more hospitals under construction in Colorado and one in Houston. The hospital in Louisiana is slated to begin its operations by the end of the year.
ADEPTUS HEALTH Price and EPS Surprise
ADEPTUS HEALTH Price and EPS Surprise | ADEPTUS HEALTH Quote
However, second-quarter results are expected to be hurt by operating losses from the First Texas Hospital, along with incremental operating costs related to the launch of new hospitals.
Earnings Whispers
Our proven model does not conclusively show that Adeptus Health is likely to beat earnings this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. This is not the case here as you will see below.
Zacks ESP: Adeptus Health currently has an Earnings ESP of 0.00%. This is because the Most Accurate estimate and the Zacks Consensus Estimate for the stock stand at 48 cents.
Zacks Rank: Adeptus Health carries a Zacks Rank #5 (Strong Sell). Please note that we caution against stocks with a Zacks Rank #4 or 5 (Sell-rated) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks to Consider
Here are some companies you may want to consider as our model shows they have the right combination of elements to post an earnings beat this quarter:
CytRx Corporation with an Earnings ESP of +15.00% and a Zacks Rank #1.
Innoviva Inc. (INVA - Free Report) with an Earnings ESP of +25.00% and a Zacks Rank #1.
WellCare Health Plans Inc. with an Earnings ESP of +1.45% and a Zacks Rank #1.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>